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Abstract
Two members of the Cryptococcus neoformans-gattii species complex, the etiologic agents of cryptococcosis, can be
differentiated by biological, biochemical, serological and molecular typing techniques. Based on their differences in carbon
and nitrogen utilization patterns, cost effective and very specific diagnostic tests using D-proline and canvanine-glycine-
bromthymol blue (CGB) media have been formulated and are widely used for identification of the two species. However,
these methods have yet to be tested for strains with confirmed molecular types to assess the degree of specificity for each
molecular type in the two species. We collected global isolates of every major molecular type available and tested their
patterns of nitrogen utilization. We confirmed specificity of the CGB test to be 100% regardless of molecular type while the
D-proline test yielded 8–38% false negative results in three of the four C. gattii molecular types, VGI–VGIII. The utilization
pattern of a new set of amino acids: D-alanine, L-tryptophan and L-phenylalanine, showed species specificity comparable to
that of D-proline. We discovered that the transcription factor Gat1 (Are1) regulates the utilization of nitrogen differently
between C. neoformans and C. gattii strains. Unlike in C. neoformans, expression of the genes encoding glycine
decarboxylase complex in C. gatti was only partially suppressed by nitrogen catabolite repression in the presence of
ammonium. GAT1 in C. neoformans controlled the induction of three of the four genes encoding the glycine decarboxylase
complex when glycine was used as the sole nitrogen source while in C. gattii its regulation of these genes was less stringent.
Moreover, while virulence of C. neoformans strains in mice was not affected by Gat1, the transcription factor positively
influenced the virulence of C. gattii strain.
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Introduction
Two members of Cryptococcus neoformans-gattii species complex (Csc)
are basidiomycetous yeasts that causes cryptococcosis in humans
and animals world-wide [1]. Two closely related sister species, C.
neoformans and C. gattii each composed of various subtypes are
recognized within the complex [2]. Based on M13 DNA-
fingerprinting [3], Amplified Fragment Length Polymorphism
(AFLP) [4] and Multilocus Sequence Typing (MLST) [5,6,7], Csc
can be separated into 8 molecular types, VNI-IV and VGI-IV that
correlate with four serotypes [8] and 3 varieties [9,10]. They are, C.
neoformans: VNI and VNII – serotype A, var. grubii; VNIII – serotype
AD; VNIV – serotype D, var. neoformans and C. gattii: VGI-IV –
serotype B or C, which was raised to species level in 2002 [11]. In
addition, a novel molecular type in C. neoformans, VNB, was recently
discovered as a unique cryptococcal population in Botswana [12].
Though very closely related, the two species are different in many
aspects. C. neoformans mainly causes meningoencephalitis in HIV
infected patients worldwide [1] except for countries in Far East Asia
where cryptococcosis is more common among non-HIV patients
[13,14]. C. gattii causes diseases more commonly in non-HIV
patients and has gained its importance recently as the causative
agent of the cryptococcosis outbreak on Vancouver Island in
Canada [15,16] and the northwest region of USA [17,18]. The
environmental source of C. neoformans reported world-wide is usually
associated with pigeon guano [10]. C. gattii, on the other hand, is
known to be associated with a variety of trees, especially Eucalyptus
trees [19] and was thought to be restricted to tropical and
subtropical areas [20]. Extensive surveys in North and South
America, however, revealed that the ecological niche of C. gattii has
been expanded to areas with temperate climates such as the Pacific
Northwest region of USA and Canada [17,18] or high mountain
regions in Colombia [21].
Previous studies have reported that the two species are
significantly different in their patterns of nitrogen and carbon
utilization. Utilization of creatinine as a nitrogen source was
among the first such studies undertaken and found that the strains
of serotype A utilize creatinine less efficiently than strains of the
other serotypes [22]. An enzymatic assay for creatinine metabo-
lism revealed that creatinine deiminase, which is expressed only in
the presence of creatinine, is repressed by ammonia in C. neoformans
but not in C. gattii [23]. Based on these findings, the creatinine
bromthymol blue agar was formulated to effectively differentiate
the strains of C. neoformans from C. gattii [23]. D-proline utilization
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medium was reported to be highly specific for the differentiation of
the two species [24,25]. The enzymatic mechanism of D-proline
metabolism, however, has not been studied. C. gattii is known to
utilize glycine and dicarboxylic acids as carbon sources more
effectively than C. neoformans [22,26]. While 88% of C. gattii strains
utilized glycine, only 20% of C. neoformans strains were reported to
utilize glycine as a carbon source [26]. A combination of L-
canavanine and glycine in the medium allowed 100% differenti-
ation between the two species among the 101 strains of C.
neoformans and the 70 strains of C. gattii tested [27]. A further study
from Brazil confirmed the high specificity of the canavanine
glycine medium for the differentiation of the two species; only 1
out of 233 strains tested produced an ambiguous result [25].
Utilization of limited nitrogen sources in the host environment is
crucial for growth of any pathogenic organism. In order to
efficiently regulate the use of nitrogen when abundant, nitrogen
catabolite repression (NCR) or nitrogen metabolite repression is
induced. NCR ensures the use of preferred nitrogen sources first
by suppressing the degradative pathways for secondary nitrogen
sources until the readily assimilable nitrogen sources have been
exhausted [28,29]. GATA transcription factors are known to play
an important role in regulating the expression of nitrogen-
regulated genes [28]. The GATA transcription factor, AreA,
Nit2 and Gln3 were among the first and most important
transcription factors to be characterized in ascomycetous fungi
[28,29,30,31,32]. It mediates NCR and is required for utilization
of secondary nitrogen sources. Apart from its role in nitrogen-
regulation, GAT1 also contributes to the virulence of pathogenic
fungi in both humans [32,33] and plants [34]. Disruption of GAT1
significantly reduced the virulence of Candida albicans [32] and
Aspergillus fumigatus [33] in a mice model. In C. neoformans, the role
of GAT1 was extensively characterized where a relationship was
observed between the transcription factor and the genes that are
associated with cryptococcal virulence [35,36]. GAT1 has been
shown to regulate melanin synthesis, capsule production, mating
in vitro and virulence in either invertebrate and vertebrate hosts
[35]. In spite of the apparent differences between C. neoformans and
C. gattii in the utilization of several nitrogen sources, the role of
GAT1 in regulation of nitrogen assimilation has not been studied.
Although cryptococcosis caused by both species was discovered
more than 100 years ago [2,37], most studies have focused on C.
neformans and relatively little attention has been paid to C. gattii.
Comparative biological studies between the two species were
mostly carried out prior to the advent of AIDS epidemics
[22,27,38,39,40]. However, after the cryptococcosis outbreak
caused by C. gattii on Vancouver Island Canada in 1999 [15], C.
gattii has gained prominence as a primary pathogen. Genetic
characterizations of C. gattii have been conducted mostly to
decipher the virulence traits of the species [41,42,43,44,45] and
not its ability to utilize nitrogen or carbon. Since these biochemical
features are crucial for understanding the differences in pathobi-
ology between the two species, we compared the GAT1 regulation
of the amino acid utilization and its effect on virulence.
Results
Utilization of nitrogen sources
Initial screening of nitrogen utilization was performed with H99
[46] and R265 [15] as the reference strains of C. neoformans and C.
gattii, respectively, since these two genome sequenced strains are
typically used for molecular genetics and pathogenesis studies [1].
Nitrogen sources used in the study included 23 amino acids (see
Fig. 1) and ammonium sulfate. Yeast peptone glucose (YPD) agar
was used as a positive control for growth and yeast nitrogen base
(YNB) with 2% glucose but without amino acids and ammonium
sulfate (Fig. 1, Blank) was used as a negative control. As shown in
Figure 1, utilization of the nitrogen sources was comparable
between the two species except for L-phenylalanine, L-tryptophan,
D-proline and D-alanine. Although threonine utilization was also
different between the two strains, the difference was not as robust
as with the aforementioned four amino acids (Fig. 1). While D-
proline and D-alanine were utilized exclusively by R265, L-
phenylalanine and L-tryptophan were utilized by H99 significantly
better than R265. We randomly selected 67 strains of all the
known major molecular types (8 VNI, 3 VNII, 3 VNB, 6 VNIII,
11 VNIV, 8 VGI, 12 VGII, 11 VGIII and 5 VGIV). The
molecular types of the strains were confirmed by URA5-RFLP and
then the strains were tested for utilization of the four amino acids
as the source of nitrogen (Table 1). The results were compared
with the standard CGB test (Table 1) and the species specificity of
the amino acid utilization was summarized (Table 2). The CGB
test was species specific, regardless of molecular type. Interestingly,
utilization of D-alanine was found to be more species specific than
D-proline which has been the second most widely used reagent to
differentiate between the two species. While the test involving
utilization of D-proline did not yield any false positive results for
the C. neoformans strains, six of the 36 (17%) C. gattii strains were
false negative. False negatives were obtained for three of the four
C. gattii molecular types (VGI–VGIII) with the highest frequency
observed among strains of molecular type VGI (38%) followed by
VGIII (18%) and VGII (8%). No false negative results were
obtained with VGIV strains. As is the case with D-proline, no C.
neoformans strains utilized D-alanine (Table 2) while 94% (34/36) of
the C. gattii strains were able to utilize D-alanine as the sole source
of nitrogen. Interestingly, false negatives for D-alanine were only
obtained for strains of the VGI molecular type (25%). Among the
C. gatti strains tested, only 6% could utilize L-Phenylalanine while
none could utilize L-Tryptophan as a nitrogen source (Tables 1
and 2). Interestingly, the ability to utilize L-Phenylalanine or L-
Tryptophan as a nitrogen source was specific to only the VNI,
VNII, VNB (serotype A/var. grubii; 93% for L-Phenylalanine and
79% for L-tryptophan) and VNIII, the serotype A/D hybrid
(100% for either L-Phenylalanine or L-Tryptophan) molecular
type strains. Most VNIV strains (82%) poorly utilized L-
Phenylalanine or L-Tryptophan as the sole nitrogen source
(Tables 1 and 2).
Regulation of amino acid utilization by GAT1 is different
between the two species
Previous study on the differences in creatinine metabolism
between C. neoformans and C. gattii [47] suggested that the
divergence in nitrogen utilization between the two species could
be due to their differences in NCR (Nitrogen Catabolite
Repression). Creatinine deiminase, a key enzyme for creatinine
metabolism, was found to be repressed in C. neoformans but not in
C. gattii by accumulation of ammonium in the growth medium
[47]. Importance of the NCR mechanism in nitrogen utilization
has been emphasized by recent studies in C. neoformans [35,36].
GAT1, a GATA transcription factor, is required for utilization of
all of the tested nitrogen sources via the NCR mechanism [35].
Thus, we identified and disrupted the GAT1 gene in both species
and compared the control of nitrogen utilization by GAT1. The
GAT1 gene in R265 was identified as CNBG_0368 based on its
sequence similarity with the H99 GAT1 (CNAG_00193) [36]. As
shown in Figure 2, the gat1D strains of H99 and R265, as
representatives of the two species, differed significantly in their
ability to utilize various nitrogen sources. Growth of R265gat1D
Nitrogen Metabolism of C. neoformans and C. gattii
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tested except for proline and arginine where only a slight reduction
was observed for both species. Unlike C. neoformans, only a slight
reduction of alanine utilization was observed in C. gattii. Growth of
R265gat1D on L-leucine, L-lysine, and L-aspartate was signifi-
cantly reduced compared to H99gat1D. On the other hand, GAT1
disruption caused only slight reduction in the growth of R265 on
glycine and creatinine while the GAT1 disruption in H99 totally
abolished its ability to utilize the same nitrogen source (Fig. 2).
Complementation of GAT1 restored the wild type level of ability to
utilize different amino acids as the sole nitrogen source (Fig S1).
The expression levels of genes encoding glycine
cleavage enzymes are controlled by nitrogen catabolite
repression less stringently in C. gattii than in C.
neoformans
Since utilization of glycine as both the carbon and the nitrogen
source has been used to differentiate between the two species [27],
we compared the regulation of glycine utilization between H99
and R265 as representatives of the two species. In Saccharomyces
cerevisiae, glycine is utilized as a nitrogen source via cleavage by the
glycine decarboxylase complex which is controlled by NCR [48].
C. neoformans and C. gattii both contain the S. cerevisiae orthologs
encoding 4 subunits of the glycine decarboxylase complex: the T-
protein (encoded by GCV1 [49]), P-protein (encoded by GCV2
[50]), H-protein (encoded by GCV3 [51]) and L-protein (encoded
by LPD1 [52]). Though the function of these proteins has not been
confirmed experimentally, a similar function of the enzymes
reported in S. cerevisiae indicates that these enzymes are highly
conserved across fungal species. Thus, we analyzed the GAT1
regulation of these genes by comparing transcriptional profiles of
these genes in the two species using quantitative PCR (qPCR). In
H99, expression of all four genes was significantly up-regulated
when glycine was used as the sole nitrogen source compared to
ammonium sulfate (Fig. 3A). In R265, however, such robust
increases were not observed for the expressions of GCV3 and LPD1
(Fig. 3A). In H99, the addition of ammonium sulfate to the glycine
media completely suppressed the expression of all 4 genes down to
the levels observed with ammonium sulfate alone. However, in
R265, the expression of GCV1 and GCV2 was only partially
suppressed upon addition of ammonium sulfate (Fig. 3A). These
results suggest that expression of two of the genes encoding glycine
decarboxylase complex in R265 is not subject to the tight
regulation by nitrogen catabolite repression as in H99.
We also examined the roles of GAT1 in regulating the
expression of glycine decarboxylase complex genes. Although
expression of the four glycine decarboxylase genes in H99gat1D
were induced when glycine was used as the sole nitrogen source,
the induction levels of GCV1, GCV2 and GCV3 were not as high as
in the wild type (GCV1: wt/gat1D=1.91, p=0.05; GCV2: wt/
gat1D=2.55, p=0.01; GCV3: wt/gat1D=1.8, p=0.04, Fig. 3B).
These data suggest that GAT1 in H99 plays a role in derepressing
the expression of these four genes and some factor(s) yet to be
identified also regulates their induction when glycine is used as the
sole nitrogen source. In R265gat1D, on the other hand, the
expression levels of these four genes were close to wild type levels.
These data suggest that the role of GAT1 is less prominent in R265
than in H99 with respect to expressison of the four glycine
decarboxylase genes when glycine is the sole nitrogen source.
GAT1 regulates virulence differently between C.
neoformans and C. gattii
Two previous studies have shown that disruption of GAT1 in
H99 altered its virulence [35,36]. We compared the impact of
GAT1 deletion in H99 and R265 on the expression of virulence
factors in vitro including melanin and capsule production, ability
to grow at 37uC and cell wall integrity in the presence of caffeine.
Expression of the LAC1 gene which encodes laccase responsible for
Figure 1. Utilization of nitrogen sources by H99 and R265. 5 ml of cell suspensions at OD600nm of 10, 0.1 and 0.001 were spotted on 2%
glucose YNB agar with 10 mM of the indicated nitrogen source and incubated for 5–7 days at 30uC. Amino acids differentially utilized by the two
species are italicized and underlined.
doi:10.1371/journal.pone.0034258.g001
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Name Country Species
Molecular
type D-Proline D-Alanine L-Phenylalanine L-Tryptophan CGB
B5763 unknown C. gattii VGI 222 2 +
B5765 unknown C. gattii VGI ++22 +
B5788 unknown C. gattii VGI ++22 +
NIH254 unknown C. gattii VGI 222 2 +
WM179 Australia C. gattii VGI 2 + 22 +
WM276 Australia C. gattii VGI +++ 2 +
B4506 Australia C. gattii VGI ++22 +
NIH76 unknown C. gattii VGI ++22 +
475061 Thailand C. gattii VGII ++22 +
B4534 unknown C. gattii VGII ++22 +
H001875 Colombia C. gattii VGII ++22 +
H001941 Colombia C. gattii VGII 2 + 22 +
McBride Australia C. gattii VGII ++22 +
NIH444 USA C. gattii VGII ++22 +
R265 Canada C. gattii VGII ++22 +
R272 Canada C. gattii VGII ++22 +
Ram002 Australia C. gattii VGII ++22 +
RB1 Canada C. gattii VGII ++22 +
VPB058 Australia C. gattii VGII ++22 +
WM178 Australia C. gattii VGII ++22 +
NIH18 unknown C. gattii VGIII 2 + 22 +
NIH113 unknown C. gattii VGIII ++22 +
NIH409 unknown C. gattii VGIII ++22 +
CN043S New Zealand C. gattii VGIII ++22 +
CN043W New Zealand C. gattii VGIII ++22 +
H0078 Colombia C. gattii VGIII ++22 +
H00818 Colombia C. gattii VGIII ++22 +
NIH191 USA C. gattii VGIII ++22 +
NIH312 unknown C. gattii VGIII ++22 +
NIH744 unknown C. gattii VGIII 2 + 22 +
WM175 USA C. gattii VGIII ++22 +
105 unknown C. gattii VGIV ++22 +
LA390 Mexico C. gattii VGIV ++22 +
H001686 Colombia C. gattii VGIV ++22 +
NIH535 unknown C. gattii VGIV ++22 +
WM779 South Africa C. gattii VGIV ++22 +
Bt85 Botswana C. neoformans VNB 22++ 2
Bt88 Botswana C. neoformans VNB 22++ 2
Bt131 Botswana C. neoformans VNB 22++ 2
NIH289 unknown C. neoformans VNI 22++ 2
C48 USA C. neoformans VNI 22++ 2
H99 USA C. neoformans VNI 22++ 2
It743 Italy C. neoformans VNI 22++ 2
JP1088 Japan C. neoformans VNI 22++ 2
Mal212 Malawi C. neoformans VNI 22++ 2
WM148 Australia C. neoformans VNI 22++ 2
NIH394 unknown C. neoformans VNI 222 2 2
NIH281 unknown C. neoformans VNII 22+ 22
NIH286 unknown C. neoformans VNII 22++ 2
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important for the virulence in both species [43,54]. The gat1D
strains of both H99 and R265 exhibited an increase in melanin
production (gat1D/wt=10.26, p=0.001 and 2.9, p=0.023 for
H99 and R265, respectively) and the expression of LAC1 was
found to be upregulated (gat1D/wt=14.5, p=0.001 and 3.2,
p=0.007 for H99 and R265, respectively) (Fig. 4A and 4B). When
capsule production was compared in RPMI media with 5% CO2
at 37uC, only the gat1D strain of R265 but not of H99 produced a
larger capsule than the wild type (gat1D/wt=1.00, p=0.915 and
1.17, p=0.001 for H99 and R265, respectively) (Fig. 4C and 4D).
However, neither R265gat1D nor H99gat1D showed any difference
in growth rate at 37uC compared to wild type (Fig. 5A). However,
a slight increase was observed in the tolerance to 1 mg/ml caffeine
(Fig. 5B), a cell wall perturbing agent which has been used to test
cell wall integrity of both species [43,55]. Next, we compared the
virulence between gat1D and wild type strains using a murine
inhalation model. As reported previously, virulence of H99gat1D
was slightly enhanced compared to H99 (p=0.141, Fig. 6) [35,36].
Surprisingly, however, virulence of R265gat1D was significantly
more reduced than the wild type (p=0.024, Fig. 6).
Discussion
The ability to utilize specific nitrogen and carbon sources is
among the standard methods used for the identification of yeast
Table 1. Cont.
Name Country Species
Molecular
type D-Proline D-Alanine L-Phenylalanine L-Tryptophan CGB
WM626 Australia C. neoformans VNII 22+ 22
CBS132 Japan C. neoformans VNIII 22++ 2
KW5a Kuwait C. neoformans VNIII 22++ 2
NIH304 unknown C. neoformans VNIII 22++ 2
RKIM364 Germany C. neoformans VNIII 22++ 2
SpaE13 Spain C. neoformans VNIII 22++ 2
TBS54 India C. neoformans VNIII 22++ 2
NIH487 unknown C. neoformans VNIV 222 2 2
NIH310 unknown C. neoformans VNIV 22++ 2
NIH531 unknown C. neoformans VNIV 22++ 2
B3501 USA C. neoformans VNIV 222 2 2
B3502 USA C. neoformans VNIV 222 2 2
JEC20 USA C. neoformans VNIV 222 2 2
JEC21 USA C. neoformans VNIV 222 2 2
NIH12 unknown C. neoformans VNIV 222 2 2
NIH430 unknown C. neoformans VNIV 222 2 2
NIH433 unknown C. neoformans VNIV 222 2 2
WM629 Australia C. neoformans VNIV 222 2 2
doi:10.1371/journal.pone.0034258.t001
Table 2. Utilization of different nitrogen sources according to molecular type.
Species Molecular type
C.n. C.g. VNI VNB VNII VNIII VNIV VGI VGII VGIII VGIV
D-proline negative 31 6 8 3361 1 3 120
positive 0 30 0 000051 19 5
D-alanine negative 31 2 8 3361 1 2 000
positive 0 34 0 000061 21 15
L-Phenylalanine negative 10 35 1 0 0097 1 2 1 1 5
positive 21 1 7 3 3621 000
L-Tryptophan negative 12 36 1 020981 21 15
positive 19 0 7 31620 000
CGB negative 31 0 8 3361 1 0 000
positive 0 36 0 00008 1 2 1 1 5
C. n.=Cryptococcus neoformans and C.g.=Cryptococcus gattii. Bold italic are test giving 100% correlation with either species.
doi:10.1371/journal.pone.0034258.t002
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tiation of the two species in Csc also has been effectively carried out
by both nitrogen and carbon utilization tests [24,25,26,27,47].
However, the efficacies of these biochemical tests were established
long before molecular strain typing methods became available and
the validity of these tests could have been compromised since the
populations tested could contain strains of the same genotype. For
example, previous studies have reported 100% [24] and 95% [25]
specificity for D-proline utilization by C. gattii while we found a
much lower specificity; only 80% of C. gattii strains yielded positive
results in contrast to the 100% that were negative for C. neoformans.
The CGB media, on the other hand, showed 100% specificity
between the two species regardless of molecular type. Remarkably,
the false negatives observed for D-proline utilization were found
mainly among strains of the VGI and VGIII (5 negatives among 6
strains) molecular types. According to the phylogenetic analysis of
global Csc strains based on multi gene sequence analyses, the VGI
and VGIII molecular types formed a separate cluster with high
bootstrap supports [6,7]. Our results underscore the biological
variation between different molecular types within C. gattii.
Upon screening for utilization of various amino acids as sole
nitrogen sources, we discovered a new set of amino acids,
phenylalanine, tryptophan and D-alanine, that could discriminate
C. neoformans from C. gattii strains with reasonably high specificity.
In fact, a previous study with much fewer numbers of strains also
showed the discriminating power of phenylalanine and tryptophan
utilization between the two species [35]. D-alanine has not been
studied as the sole nitrogen source for differentiation of the two
species. Our study showed that utilization of D-alanine has a
higher discrimination power than that of D-proline, the second
most commonly used diagnostic reagent next to CGB medium.
Although rare, false negatives or questionable results on CGB
media have been reported [25,59,60,61] and these new sets of
amino acid utilization panels can be applied to such rare strains.
However, the strains with questionable CGB results might also
yield ambiguous results with other nitrogen sources if the
ambiguity is caused by a mutation in the genes associated with
nitrogen metabolism. C. gattii strains that produce questionable
CGB results can be tested for growth on tryptophan media in
order to correct identify the questionable strains. Although
molecular techniques enable confirmation of species identity, use
of the one-step diagnostic media employing a species specific
nitrogen source could be a cost effective option for developing
countries with limited resources.
The nitrogen regulation by NCR in C. neoformans was studied
based on the role of the GATA-type transcriptional activator Gat1
[35,36]. As expected, Gat1 control of nitrogen regulation in the
two species showed only minor differences. For example, Gat1
control of glycine utilizations in C. gattii was not as stringent as in
C. neoformans while it was opposite in the utilization of aspartate.
These results were supported by transcription analysis of the four
genes encoding the glycine cleavage enzyme complex where the
induction of these genes was positively controlled by Gat1 in C.
neoformans but to a less extent in C. gattii. In addition, the NCR of
Figure 2. Disruption of GAT1 reduced ability to utilize all nitrogen sources. Wild type and gat1D strains were grown for 5–7 days at 30uCo n
2% glucose YNB with 10 mM of different nitrogen sources. 5 ml cell suspensions at OD600nm of 10, 0.1 and 0.001 were spotted on the media. YPD
and Blank (no nitrogen source) served as positive and negative control respectively.
doi:10.1371/journal.pone.0034258.g002
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encoded enzymes in the glycine cleavage decarboxylase complex were determined in cells growing in ammonium sulfate (NH4), glycine or glycine
plus ammonium sulfate (glycineNH4) as the sole nitrogen source. Expression is presented in folds of wild type levels growing in ammonium sulfate.
A) Expression levels of the four genes in the wild type strains. B) Effect of GAT1 deletion on the expression of glycine decarboxylase complex genes.
The experiment was carried out in triplicates. Bars=standard error, wt=wild type.
doi:10.1371/journal.pone.0034258.g003
Figure 4. Disruption of GAT1 enhanced melanin synthesis and LAC1 expression in both species but capsule size increased only in
R265. A) Cells were grown in melanin induction media using 10 mM proline as the nitrogen source. Melanin production was assayed by measuring
the absorbance at 475 nm and B) LAC1 expressions were quantified by real time PCR. C) Micrograph of cell grown in capsule induction media. D) The
relative capsule size was measured in .100 cells for each strain grown in capsule induction media. Experiments were carried out in triplicates.
* p#0.05 by the student t-test. Error bars=2 standard deviation.
doi:10.1371/journal.pone.0034258.g004
Nitrogen Metabolism of C. neoformans and C. gattii
PLoS ONE | www.plosone.org 7 March 2012 | Volume 7 | Issue 3 | e34258glycine utilization in the presence of ammonium was clear-cut in
C. neoformans but not in C. gattii. The difference in NCR of glycine
utilization between the two species is reminiscent of creatinine
metabolism where creatinine deiminase was inhibited by the
accumulation of ammonium only in C. neoformans and not in C.
gattii. As a result, growth of C. neoformans on creatinine media is
considerably slower compared to C. gattii and creatinine
bromthymol blue agar was the first one-step diagnostic media
formulated to differentiate between the two species [47].
Moreover, it has been known that glycine metabolism is controlled
by a complex process involving several genes [48,62,63]. For
example, in S. cerevisiae, glycine can be synthesized from or
converted to serine and threonine by serine hydroxymethyltrans-
ferase (Shm1 and Shm2) and threonine aldolase (Gly1). However,
both species of Csc do not utilize threonine as effectively as other
amino acids (Fig. 1) suggesting that the Gly1 role in glycine
metabolism is minimal in Csc as has been reported in Candida
albicans [64]. However, Shm1 may play a role in glycine
metabolism in Csc since expression of SHM1 was up-regulated
10 fold in both species when glycine was used as the nitrogen
source instead of ammonium sulfate (data not shown). The
nitrogen catabolic pathway, therefore, appears to be complex and
further studies are needed to elucidate the pathways in Csc.
The ability to survive in a limited nutrient environment in the
host is crucial for the growth of pathogenic organisms. For
example, Gat1 influences virulence of several pathogenic fungi
including, Aspergillus fumigatus and C. albicans [32,33,35,36]. Our
results on the virulence of H99gat1D is similar to the findings of
Lee et al. [35] but different from that of Kmetzsch et al. [36].
Interestingly, we found that gat1D behaved differently between the
two species in controlling the expression of some virulence factors
in vitro and virulence in animals. It was surprising to observe that
several virulence factors including capsule production, melanin
synthesis and cell wall integrity, were negatively controlled by
Gat1 in C. gattii while the virulence of R265gat1D was decreased in
mice. In the host environment, the impact of impaired nitrogen
utilization due to the lack of Gat1 function may be compensated
by the increase in the virulence factors. The different impact of
Gat1 in virulence between the two species might stem from the
differences in their natural habitat and hence their pathobiology. It
has been speculated that the virulence factors of the Cryptococcal
species have evolved to combat their environmental predators
such as soil amoeba and nematodes [65]. Pigeon droppings, the
primary environmental niche of C. neoformans, is high in
ammonium concentration and Gat1 may be constantly down-
regulated while the primary natural habitat of C. gattii is detritus of
trees which should be much lower in ammonium content than
pigeon guano. This would have had a different impact on
evolution of the role of Gat1 in regulation of virulence factors.
However, whether the slight impact of Gat1 on the regulation of
virulence factors observed in this study benefits survival of Csc in
nature is unclear.
In conclusion, our study points out the different aspects of
nitrogen metabolism between C. neoformans and C. gattii, two closely
related etiologic agents of cryptococcosis. The range of nitrogen
sources that can be used to differentiate between the two species
has been expanded from previous studies to include a few more
amino acids. The difference in nitrogen metabolism was confirmed
by differences in nitrogen regulation by Gat1 and ammonium
NCR which has a distinct effect on virulence between the two
species. The difference in nitrogen utilization and its regulation by
Figure 5. The role of GAT1 in cell growth. A) GAT1 is not associated
with the growth rate of both species. Cell suspensions of 2 OD600 were
spotted on YPD agar in three 10 fold dilutions and incubated for three
days at the designated temperatures B) Similar spot assays were carried
out on YPD with or without caffeine and plates were incubated at 30uC
for 3 days. Experiments were carried out in duplicates.
doi:10.1371/journal.pone.0034258.g005
Figure 6. Virulence of H99gat1D was minimally enhanced while
of R265gat1D was significantly reduced in murine inhalation
model. 50,000 cells from each strain were inoculated intrapharyngeally
to 10 Balb/c mice per group. Mice were fed with food and water ad
libitum.
doi:10.1371/journal.pone.0034258.g006
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characterization of the genes and metabolic pathways responsible
for the differences. Global screening techniques namely transcrip-
tome comparisons via cDNA microarrays and construction of
Agrobacterium tumefaciens mediated insertional libraries [66] are
currently being undertaken to elucidate the complex regulatory
network of nitrogen metabolism in Csc.
Materials and Methods
Ethics Statement
The animal experiments were carried out with the approval and
oversight of the Animal Care and Use Committee of the National
Institute of Allergy and Infectious Diseases, United States National
Institutes of Health, Bethesda MD.
Strains and media
A global collection of 8 molecular types consisting of 31 C.
neoformans and 36 C. gattii strains were revived from 280uC freezers
of Molecular Microbiology Section, Laboratory of Clinical
Infectious Diseases, NIAID, NIH, Bethesda, MD, USA and
Molecular Mycology Research Laboratory, Westmead Hospital,
Westmead, NSW, Australia. Molecular types of each strain were
confirmed by URA5-RFLP as previously described (data not
shown) [3] (Table 1). Cells were maintained on YPD agar (2%
glucose, 1% yeast extract, 2% peptone and 2% Bacto agar) until
use. For nitrogen utilization tests, cell suspensions were diluted to
0.02 OD600 nm for a single spot test or 10, 0.1 and 0.001 for
serial dilution spot tests. The cell suspensions were spotted on 2%
glucose YNB media (Becton, Dickinson and company, Sparks,
MD, USA) with or without 10 mM of each indicated nitrogen
source (Sigma-Aldrich, St. Louis, MO, USA) and incubated for 5–
7 days at 30uC. For D-proline and D-alanine utilization tests, the
results were recorded as negative when the growth was lower or
equal to the growth on media without nitrogen source (Blank). For
L-phenylalanine and L-tryptophan, results were recorded as
negative when the strains grew poorly (see Fig. 7). CGB tests
were carried out as described before and recorded as positive when
the medium turns from yellow green to blue [27]. The nitrogen
utilization tests were performed in duplicate or triplicate when
differences were either evident or the experimental results were
expected to fluctuate.
Identification of gene orthologs
Protein sequences of each gene from S. cerevisiae genome project
(http://www.yeastgenome.org/) were used to perform the BlastP in C.
neoformans H99 genome project (http://www.broadinstitute.org/
annotation/genome/cryptococcus_neoformans/MultiHome.html)
and C. gattii R265 genome project (http://www.broadinstitute.
org/annotation/genome/cryptococcus_neoformans_b/MultiHome.
html). Genes were identified as follows (C. neoformans/C. gattii): GAT1–
CNAG_00193/CNBG_0368, GCV1 – CNAG_02818/CNBG_
3472, GCV2 – CNAG_01594/CNBG_3846, GCV3 –C N A G _
06316/CNBG_5135, LPD1 – CNAG_02851/CNBG_5871.
Gene disruptions and complementations
Disruption constructs of GAT1 were created using overlapping
PCR to link the 59 and 39 flanking region to nourseothricin
antibiotic cassette [67]. The disruption constructs were trans-
formed by biolistic transformation as described previously [68].
Transformants were selected on YPD containing nourseothricin.
Homologous integrations were confirmed by PCR and southern
hybridization. Disruptants were complemented by homologous
integration of GAT1 gene into gat1D using biolistic transformation.
As none of gat1D was able to utilize L-serine as the sole nitrogen
source, transformants grown on serine media (2% glucose YNB
with 10 mM L-serine) were analyzed for the homologous
complementations by PCR and confirmed by southern hybrid-
ization. (See table S1 for primers details)
Quantitative real-time PCR
Strains were grown in YPD broth overnight to mid log phase.
Cells were washed 3 times with 16 phosphate buffered saline
(PBS: 137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, and
2m MK H 2PO4, pH 7.4) and re-suspended (1 OD600) in 2%
glucose YNB supplemented with 10 mM of the specified nitrogen
source. Cells were then grown at 30uC for 2 hrs and harvested for
RNA extraction. Cell pellets were frozen and lyophilized. RNAs
were extracted using RNA by TrizolH reagent (Invitrogen,
Carlsbad, CA, USA) and cDNAs were generated by the Super-
cript III first-strand synthesis system (Invitrogen, Carlsbad, CA,
USA) according to the manufacturer’s protocol. Quantitative real-
time PCR were performed using SYBR greener supermix
(Invitrogen, Carlsbad, CA, USA) in Applied Biosystems 7500
Real-Time PCR System. Experiments were performed in
triplicates using a relative standard curve method. (see Table S1
for primers details).
Melanin production
Quantification of laccase activity for melanin synthesis was
performed in triplicate according to the described method [69]
with modification, using 0.1% glucose YNB without amino acid
and ammonium chloride (Becton, Dickinson and Company, MD,
USA) with 10 mM proline and 1 mM epinephrine (Sigma-
Aldrich, MD, USA) at 30uC. L-proline was used as a nitrogen
source due to its minimal growth reduction upon GAT1 disruption
[35]. Culture supernatant was obtained after 24 hours and assayed
by measuring the absorbance at OD475nm using DU-64
spectophotometer (Beckman coulter, Fullerton, CA).
Capsule formation
Amount of capsule produced was quantified by comparing the
size ratio between cell with the capsules vs naked yeast (cell wall to
cell wall diameter) as has been reported previously [43]. Briefly,
each strain was grown overnight in YPD broth at 30uC. Yeast cells
were harvested, washed and inoculated into capsule inducing
RPMI with MOPS, HCO3, pH 7.3 and grown to a cell density of
10
6–10
7 cells/ml at 37uC with 5% CO2 for 72 hr [35,70]. Capsule
size of the cells stained with India ink was quantified by light
microscopy.
Figure 7. Examples of positive and negative growth on each
nitrogen source. Cells were grown on 2% glucose YNB with 10 mM of
each nitrogen source for 5–7 days at 30uC. 2 ml cell suspensions at an
OD600nm of 0.02 were spotted on the media. Limitted growth on L-
phenylalanine and L-tryptophan media was designated as negatives.
doi:10.1371/journal.pone.0034258.g007
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perturbing agent
Strains were grown on YPD with or without 1 mg/ml caffeine,
a known cell wall perturbing agent [43,55] at 30uCo r3 7 uC. Serial
dilution spot test were carried out as described in the figure
legends.
Virulence in mice
BALB/c mice were inoculated with 50,000 yeast cells via
intrapharyngeal inhalation as described [71,72]. Briefly, cells were
diluted in phosphate buffered saline (PBS) to 2.5610
6 cells/ml.
Mice were anesthetized by isoflurane and partially hung by
placing their incisors on a string while their lower back lie to a
support patch. Tongues of the mice were gently held in full
extension with padded forceps while a 20 ml suspension was
pipetted onto the base of the tongue. Mice were allowed to breathe
in the solution for 10 seconds. Tongues were then released and
mice were placed in their cages to recover. Survival was monitored
for 50 days.
Statistical analysis
All statistical analyses specified were performed in SPSS 17.0
(IBM Inc., Armonk, New York).
Supporting Information
Figure S1 Examples of GAT1/AREA complementation
which restored nitrogen utilization to the wild type level.
Wild type, gat1D and complemented strains were grown on 2%
glucose YNB with 10 mM of each nitrogen source for 5–7 days at
30uC. . 5 ml of cells at OD600nm of 10, 0.1 and 0.001 were spotted
on the media.
(TIF)
Table S1 Primers details.
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